The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial

The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial

Item
http://www.wikidata.org/entity/Q34984126
The PI3K/Akt Pathway in Tumors of Endocrine TissuesmicroRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and ChallengesAdrenocortical carcinoma (ACC): diagnosis, prognosis, and treatmentThe challenge of developmental therapeutics for adrenocortical carcinomaProgrammed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.Development of adrenal cortex zonation.Mouse models of adrenocortical tumors.Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis.Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.Novel targeted therapies in adrenocortical carcinoma.Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma.5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma.Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinomaTherapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
P2860

The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial

Item
http://www.wikidata.org/entity/Q34984126
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The combination of insulin-lik ...... titutional NCI-sponsored trial
@ast
The combination of insulin-lik ...... titutional NCI-sponsored trial
@en
The combination of insulin-like growth factor receptor 1
@nl
type
label
The combination of insulin-lik ...... titutional NCI-sponsored trial
@ast
The combination of insulin-lik ...... titutional NCI-sponsored trial
@en
The combination of insulin-like growth factor receptor 1
@nl
prefLabel
The combination of insulin-lik ...... titutional NCI-sponsored trial
@ast
The combination of insulin-lik ...... titutional NCI-sponsored trial
@en
The combination of insulin-like growth factor receptor 1
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932
P356
P1433
P1476
The combination of insulin-lik ...... titutional NCI-sponsored trial
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932